Does the media refer more to DCTH or KRMD?

In the previous week, Delcath Systems had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Delcath Systems and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Delcath Systems' score of -1.04 indicating that KORU Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative KORU Medical Systems 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer KRMD or TCMD?

In the previous week, Tactile Systems Technology had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Tactile Systems Technology and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Tactile Systems Technology's score of 0.62 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tactile Systems Technology 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer KRMD or BWAY?

In the previous week, Brainsway had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 6 mentions for Brainsway and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Brainsway's score of 0.61 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Brainsway 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor KRMD or SGHT?

In the previous week, Sight Sciences had 11 more articles in the media than KORU Medical Systems. MarketBeat recorded 14 mentions for Sight Sciences and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Sight Sciences' score of 0.39 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sight Sciences 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

KORU Medical Systems (KRMD) Competitors

$2.96 -0.04 (-1.33%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$2.96 +0.00 (+0.17%)

As of 10/9/2026 07:30 PM Eastern

Compare

KRMD vs. DCTH, TCMD, BWAY, SGHT, and NPCE

Should you buy KORU Medical Systems stock or one of its competitors? KORU Medical Systems's main competitors and comparable companies include Delcath Systems (DCTH), Tactile Systems Technology (TCMD), Brainsway (BWAY), Sight Sciences (SGHT), and NeuroPace (NPCE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does KORU Medical Systems compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Delcath Systems has a net margin of 0.56% compared to KORU Medical Systems' net margin of -4.03%. Delcath Systems' return on equity of 0.46% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.56%	0.46%	0.42%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

In the previous week, Delcath Systems had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Delcath Systems and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Delcath Systems' score of -1.04 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
KORU Medical Systems	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.39, meaning that its share price is 61% less volatile than the broader market.

Delcath Systems presently has a consensus target price of $23.17, suggesting a potential upside of 50.82%. KORU Medical Systems has a consensus target price of $7.00, suggesting a potential upside of 136.49%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

Delcath Systems has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	6.25	$2.70M	$0.01	1,536.00
KORU Medical Systems	$41.13M	3.31	-$2.64M	-$0.04	N/A

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Delcath Systems beats KORU Medical Systems on 13 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

KORU Medical Systems (NASDAQ:KRMD) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

KORU Medical Systems has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

In the previous week, Tactile Systems Technology had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Tactile Systems Technology and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Tactile Systems Technology's score of 0.62 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tactile Systems Technology has a net margin of 7.10% compared to KORU Medical Systems' net margin of -4.03%. Tactile Systems Technology's return on equity of 11.49% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Tactile Systems Technology	7.10%	11.49%	9.17%

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.31	-$2.64M	-$0.04	N/A
Tactile Systems Technology	$329.52M	1.54	$19.09M	$1.08	20.78

KORU Medical Systems presently has a consensus target price of $7.00, suggesting a potential upside of 136.49%. Tactile Systems Technology has a consensus target price of $38.40, suggesting a potential upside of 71.12%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Tactile Systems Technology beats KORU Medical Systems on 10 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Brainsway?

KORU Medical Systems (NASDAQ:KRMD) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

KORU Medical Systems currently has a consensus price target of $7.00, suggesting a potential upside of 136.49%. Brainsway has a consensus price target of $18.20, suggesting a potential upside of 54.63%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, equities analysts clearly believe KORU Medical Systems is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
Brainsway	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.31	-$2.64M	-$0.04	N/A
Brainsway	$52.22M	9.07	$7.57M	$0.44	26.75

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 30.1% of Brainsway shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 19.0% of Brainsway shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Brainsway had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 6 mentions for Brainsway and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Brainsway's score of 0.61 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Brainsway	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Brainsway has a net margin of 15.65% compared to KORU Medical Systems' net margin of -4.03%. Brainsway's return on equity of 12.74% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Brainsway	15.65%	12.74%	8.17%

KORU Medical Systems has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market. Comparatively, Brainsway has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

Summary

Brainsway beats KORU Medical Systems on 12 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Sight Sciences?

KORU Medical Systems (NASDAQ:KRMD) and Sight Sciences (NASDAQ:SGHT) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

KORU Medical Systems has higher earnings, but lower revenue than Sight Sciences. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.31	-$2.64M	-$0.04	N/A
Sight Sciences	$77.36M	6.33	-$38.43M	-$0.56	N/A

KORU Medical Systems has a beta of 0.39, meaning that its share price is 61% less volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.45, meaning that its share price is 145% more volatile than the broader market.

In the previous week, Sight Sciences had 11 more articles in the media than KORU Medical Systems. MarketBeat recorded 14 mentions for Sight Sciences and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.30 beat Sight Sciences' score of 0.39 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sight Sciences	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

KORU Medical Systems has a net margin of -4.03% compared to Sight Sciences' net margin of -35.69%. KORU Medical Systems' return on equity of -10.63% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Sight Sciences	-35.69%	-43.39%	-22.86%

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 136.49%. Sight Sciences has a consensus target price of $8.38, indicating a potential downside of 5.79%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe KORU Medical Systems is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
Sight Sciences	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 30.4% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

KORU Medical Systems beats Sight Sciences on 10 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

In the previous week, KORU Medical Systems had 2 more articles in the media than NeuroPace. MarketBeat recorded 3 mentions for KORU Medical Systems and 1 mentions for NeuroPace. KORU Medical Systems' average media sentiment score of 1.30 beat NeuroPace's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
NeuroPace	Neutral
KORU Medical Systems	Positive

78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 19.2% of NeuroPace shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

NeuroPace currently has a consensus target price of $19.33, suggesting a potential upside of 52.59%. KORU Medical Systems has a consensus target price of $7.00, suggesting a potential upside of 136.49%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

NeuroPace has a beta of 1.86, suggesting that its share price is 86% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market.

KORU Medical Systems has lower revenue, but higher earnings than NeuroPace. KORU Medical Systems is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	4.35	-$21.47M	-$0.57	N/A
KORU Medical Systems	$41.13M	3.31	-$2.64M	-$0.04	N/A

KORU Medical Systems has a net margin of -4.03% compared to NeuroPace's net margin of -19.34%. KORU Medical Systems' return on equity of -10.63% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-19.34%	-105.64%	-16.51%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

Summary

KORU Medical Systems beats NeuroPace on 9 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KRMD vs. The Competition

Export

Metric	KORU Medical Systems	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$137.80M	$5.43B	$7.16B	$13.21B
Dividend Yield	N/A	1.77%	2.53%	16.37%
P/E Ratio	-74.00	25.57	275.30	26.16
Price / Sales	3.31	83.34	635.97	107.50
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	8.00	5.95	11.22	6.33
Net Income	-$2.64M	$146.18M	$3.50B	$382.15M
7 Day Performance	N/A	-0.28%	-0.89%	-1.40%
1 Month Performance	-6.03%	-1.88%	-4.42%	-3.47%
1 Year Performance	-31.00%	5.45%	7.03%	1.18%

KORU Medical Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KRMD KORU Medical Systems	4.5257 of 5 stars	$2.96 -1.3%	$7.00 +136.5%	-30.7%	$137.80M	$41.13M	N/A	73	Positive News
DCTH Delcath Systems	3.0576 of 5 stars	$15.41 -2.9%	$23.17 +50.3%	+41.2%	$550.67M	$85.23M	1,542.54	156	News Coverage Analyst Downgrade
TCMD Tactile Systems Technology	3.9136 of 5 stars	$22.19 -1.2%	$38.40 +73.1%	+53.9%	$509M	$329.52M	20.55	1,086	Positive News
BWAY Brainsway	4.5989 of 5 stars	$11.89 -2.8%	$18.20 +53.1%	+51.3%	$492.20M	$52.22M	27.02	129
SGHT Sight Sciences	1.3384 of 5 stars	$8.56 -4.0%	$8.38 -2.2%	+163.0%	$491.39M	$77.36M	N/A	186

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KRMD) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KORU Medical Systems (KRMD) Competitors

KRMD vs. DCTH, TCMD, BWAY, SGHT, and NPCE

How does KORU Medical Systems compare to Delcath Systems?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Summary

How does KORU Medical Systems compare to Brainsway?

Summary

How does KORU Medical Systems compare to Sight Sciences?

Summary

How does KORU Medical Systems compare to NeuroPace?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KORU Medical Systems (KRMD) Competitors

KRMD vs. DCTH, TCMD, BWAY, SGHT, and NPCE

How does KORU Medical Systems compare to Delcath Systems?

Is DCTH or KRMD more profitable?

Does the media refer more to DCTH or KRMD?

Which has more risk & volatility, DCTH or KRMD?

Do analysts recommend DCTH or KRMD?

Which has preferable earnings & valuation, DCTH or KRMD?

Do institutionals and insiders hold more shares of DCTH or KRMD?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Which has more risk & volatility, KRMD or TCMD?

Does the media prefer KRMD or TCMD?

Is KRMD or TCMD more profitable?

Do institutionals & insiders have more ownership in KRMD or TCMD?

Which has higher earnings and valuation, KRMD or TCMD?

Do analysts prefer KRMD or TCMD?

Summary

How does KORU Medical Systems compare to Brainsway?

Do analysts rate KRMD or BWAY?

Which has preferable valuation and earnings, KRMD or BWAY?

Do institutionals and insiders have more ownership in KRMD or BWAY?

Does the media prefer KRMD or BWAY?

Is KRMD or BWAY more profitable?

Which has more risk and volatility, KRMD or BWAY?

Summary

How does KORU Medical Systems compare to Sight Sciences?

Which has better valuation and earnings, KRMD or SGHT?

Which has more risk & volatility, KRMD or SGHT?

Does the media favor KRMD or SGHT?

Is KRMD or SGHT more profitable?

Do analysts rate KRMD or SGHT?

Do institutionals & insiders believe in KRMD or SGHT?

Summary

How does KORU Medical Systems compare to NeuroPace?

Does the media refer more to NPCE or KRMD?

Do institutionals and insiders hold more shares of NPCE or KRMD?

Do analysts prefer NPCE or KRMD?

Which has more risk & volatility, NPCE or KRMD?

Which has preferable valuation & earnings, NPCE or KRMD?

Is NPCE or KRMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools